BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16014372)

  • 1. Capecitabine-warfarin interaction.
    Janney LM; Waterbury NV
    Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
    Shah HR; Ledbetter L; Diasio R; Saif MW
    Clin Colorectal Cancer; 2006 Jan; 5(5):354-8. PubMed ID: 16512995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse interaction between capecitabine and warfarin resulting in altered coagulation parameters and bleeding: case report and review of the literature.
    Isaacs K; Haim N
    J Chemother; 2005 Jun; 17(3):339-42. PubMed ID: 16038530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.
    Shah SR; Martin R; Dowell JE; Ussery SM
    Pharmacotherapy; 2010 Dec; 30(12):1259-65. PubMed ID: 21128758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
    Copur MS; Ledakis P; Bolton M; Morse AK; Werner T; Norvell M; Muhvic J; Chu E
    Clin Colorectal Cancer; 2001 Nov; 1(3):182-4. PubMed ID: 12450435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.
    Davis DA; Fugate SE
    Pharmacotherapy; 2005 Mar; 25(3):442-7. PubMed ID: 15843293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adverse interaction between warfarin and fluoropyrimidines revisited.
    Saif MW
    Clin Colorectal Cancer; 2005 Sep; 5(3):175-80. PubMed ID: 16197620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction between capecitabine and warfarin: a case report and review of the literature.
    Yildirim Y; Ozyilkan O; Akcali Z; Basturk B
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):80-2. PubMed ID: 16502767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B; Voll ML; Smorenburg CH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin-5-FU interaction--a consecutive case series.
    Kolesar JM; Johnson CL; Freeberg BL; Berlin JD; Schiller JH
    Pharmacotherapy; 1999 Dec; 19(12):1445-9. PubMed ID: 10600095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver injury possibly related to drug interaction after liver transplant: a case report.
    Zhu LQ; Jiang WT; Pan C; Liu YH; Thian Y
    J Clin Pharm Ther; 2014 Aug; 39(4):439-41. PubMed ID: 24661191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine as adjuvant treatment for stage III colon cancer.
    Twelves C; Wong A; Nowacki MP; Abt M; Burris H; Carrato A; Cassidy J; Cervantes A; Fagerberg J; Georgoulias V; Husseini F; Jodrell D; Koralewski P; Kröning H; Maroun J; Marschner N; McKendrick J; Pawlicki M; Rosso R; Schüller J; Seitz JF; Stabuc B; Tujakowski J; Van Hazel G; Zaluski J; Scheithauer W
    N Engl J Med; 2005 Jun; 352(26):2696-704. PubMed ID: 15987918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complications.
    Yood MU; Quesenberry CP; Alford SH; Tsai AL; Wells KE; Yood SM; Ackermann Shiff SP
    Curr Med Res Opin; 2006 Feb; 22(2):307-14. PubMed ID: 16466602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
    Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
    J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased anticoagulant activity of warfarin used in combination with doxifluridine.
    Nakajima M; Genda T; Suehira M; Satoh H; Miki A; Hori S; Sawada Y
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):969-72. PubMed ID: 20107800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
    Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
    J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.